A month of compounded GHK-Cu costs this much from sellers that publish a price. The market counts topical, nasal spray, oral, sublingual forms only. It sits beside the other compounds on the price boards.
$145
Typical monthly price
$69
Lowest published monthly price
$209
Highest published monthly price
30
Sellers, read through September 2026
Only 30 sellers publish a monthly figure. Each counts once, at its lowest price. The GHK-Cu price board holds the detail.
Why the injectable is not in that figure
FDA lists “GHK-Cu (except for injectable routes of administration)” in 503A Category 1[1]. The injectable route sits on no list.
The history is short. FDA removed GHK-Cu from Category 1 on April 22, 2026, after the nominations were withdrawn[1]. One nominator then asked to keep the non-injectable routes[1]. They went back on the list[1].
FDA gives its reason for concern about injection. Compounded injectable GHK-Cu may pose an immunogenicity risk from aggregation and peptide-related impurities[2]. Human data are limited[2].
Category 1 is not an approval. Under its interim policy, FDA does not intend to act against a pharmacy compounding from a Category 1 substance[3]. FDA plans to consult its advisory committee on GHK-Cu before the end of February 2027[1].
How to compare two topical prices
A jar is not a month. Ask three things.
- What concentration is the product?
- How much is applied per use, and how often?
- How many days does one container last at that rate?
Divide the price by the days. Multiply by thirty. Then add the consult or membership, if one is billed. The peptide therapy cost guide lists those fees.
What the evidence covers
A 2026 systematic review looked at GHK-Cu in aesthetic medicine[4]. It included 20 studies. Eighteen were preclinical; two were randomized trials[4].
In the clinical studies, GHK-Cu improved satisfaction after laser resurfacing. It reduced wrinkle volume and depth against controls[4]. The authors called the trial base limited and methodologically variable[4].
So the price buys a cosmetic product with a small human evidence base. That matters for payment too. Plans rarely cover it, as the insurance guide explains.